Annual ROE
354.78%
+304.37%+603.79%
December 31, 2023
Summary
- As of February 8, 2025, CLDI annual return on equity is 354.78%, with the most recent change of +304.37% (+603.79%) on December 31, 2023.
- During the last 3 years, CLDI annual ROE has risen by +319.47% (+904.76%).
- CLDI annual ROE is now at all-time high.
Performance
CLDI ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
234.37%
-26.41%-10.13%
September 30, 2024
Summary
- As of February 8, 2025, CLDI quarterly return on equity is 234.37%, with the most recent change of -26.41% (-10.13%) on September 30, 2024.
- Over the past year, CLDI quarterly ROE has increased by +159.55% (+213.25%).
- CLDI quarterly ROE is now -10.13% below its all-time high of 260.78%, reached on June 30, 2024.
Performance
CLDI Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
CLDI ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +603.8% | +213.3% |
| 3 y3 years | +904.8% | +213.3% |
| 5 y5 years | +904.8% | +213.3% |
CLDI ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +926.0% | -10.1% | +2022.9% |
| 5 y | 5-year | at high | +926.0% | -10.1% | +2022.9% |
| alltime | all time | at high | +926.0% | -10.1% | +2022.9% |
Calidi Biotherapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | 234.37%(-10.1%) |
| Jun 2024 | - | 260.78%(+90.5%) |
| Mar 2024 | - | 136.87%(+14.1%) |
| Dec 2023 | 354.78% | 120.00%(+60.4%) |
| Sep 2023 | - | 74.82%(+22.9%) |
| Jun 2023 | - | 60.87%(+46.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | 41.48%(+49.3%) |
| Dec 2022 | 50.41%(+45.8%) | - |
| Dec 2022 | - | 27.79%(+18.7%) |
| Sep 2022 | - | 23.42%(+112.1%) |
| Dec 2021 | 34.58%(-2.1%) | 11.04% |
| Dec 2020 | 35.31% | - |
FAQ
- What is Calidi Biotherapeutics annual return on equity?
- What is the all time high annual ROE for Calidi Biotherapeutics?
- What is Calidi Biotherapeutics annual ROE year-on-year change?
- What is Calidi Biotherapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Calidi Biotherapeutics?
- What is Calidi Biotherapeutics quarterly ROE year-on-year change?
What is Calidi Biotherapeutics annual return on equity?
The current annual ROE of CLDI is 354.78%
What is the all time high annual ROE for Calidi Biotherapeutics?
Calidi Biotherapeutics all-time high annual return on equity is 354.78%
What is Calidi Biotherapeutics annual ROE year-on-year change?
Over the past year, CLDI annual return on equity has changed by +304.37% (+603.79%)
What is Calidi Biotherapeutics quarterly return on equity?
The current quarterly ROE of CLDI is 234.37%
What is the all time high quarterly ROE for Calidi Biotherapeutics?
Calidi Biotherapeutics all-time high quarterly return on equity is 260.78%
What is Calidi Biotherapeutics quarterly ROE year-on-year change?
Over the past year, CLDI quarterly return on equity has changed by +159.55% (+213.25%)